Panacea Biotec, India's 3rd largest biotechnology company has introduced indigenously developed high quality Oncology product -- CABAPAN (Cabazitaxel Injection), for treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC).
Prostate is the second leading site of cancer amongst males with rising mortality rate in India. With ever changing lifestyles, increased awareness, better diagnostic techniques and increased accessibility to medical treatment, more cases of Ca Prostate are being diagnosed.
CABAPAN has been developed by the company's state of the art Global Research and Development Center (GRAND), Mumbai and manufactured at modern production facility complying with global current Good Manufacturing Practices (cGMP), at Baddi, Himachal Pradesh.
Panacea Biotec is the third largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1824.75 |
Dr. Reddys Lab | 1193.65 |
Cipla | 1564.80 |
Lupin | 2103.85 |
Zydus Lifesciences | 899.60 |
View more.. |